Arkema SA:企業の戦略・SWOT・財務分析

◆英語タイトル:Arkema SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4833
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Arkema SA – Strategy, SWOT and Corporate Finance Report
Summary

Arkema SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Arkema SA (Arkema) is a manufacturer and supplier of chemical products. The company provides 3D printing, adhesives and sealants, automotive and transportation, building and construction, coatings, paints and inks, composites and advanced materials, electronics, and electrical, oil and gas, renewable energies and energy storage, and sport and leisure products. It offers products under various brands such as Sartomer’s N3xtDimension resins, Rilsan bio-based polyamides, Kynar fluoropolymers, Kepstan PEKK, and others. The company serves the automotive, agriculture, chemicals, consumer goods, construction, electrical, oil, health and packaging industries. It has operations across the Asia Pacific, Europe, Africa and the Middle East, and the Americas. The company is headquartered in Colombes, France.

Scope

- Detailed information on Arkema SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Arkema SA in the form of a SWOT analysis
- An in-depth view of the business model of Arkema SA including a breakdown and examination of key business segments
- Intelligence on Arkema SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Arkema SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Arkema SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Arkema SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Arkema SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Arkema SA: Company Overview
Arkema SA: Overview and Key Facts
Arkema SA: Overview
Arkema SA: Key Facts
Arkema SA: Key Employees
Arkema SA: Key Employee Biographies
Arkema SA: Major Products and Services
Arkema SA: Company History
Arkema SA: Locations and Subsidiaries
Arkema SA: Key Competitors
Arkema SA: Company Analysis
Arkema SA: Business Description
Arkema SA: SWOT Analysis
Arkema SA: SWOT Overview
Arkema SA: Strengths
Arkema SA: Weaknesses
Arkema SA: Opportunities
Arkema SA: Threats
Arkema SA: Corporate Financial Deals Activity
Arkema SA: Financial Deals Overview
Arkema SA: Targets and Partners
Arkema SA: Top Deals 2016 – 2020YTD*
Arkema SA: Advisors
Arkema SA: Top Legal Advisors
Arkema SA: Top Financial Advisors
Arkema SA: Mergers and Acquisitions
Arkema SA: Corporate Venturing
Arkema SA: Capital Raising
Arkema SA: Partnership
Arkema SA: Divestments
Arkema SA: Recent Developments
Arkema SA: News and Events Summary
Arkema SA: Business Expansion
Arkema SA: Contracts
Arkema SA: Corporate Governance
Arkema SA: Financial Deals
Arkema SA: Financial Performance
Arkema SA: Market Developments
Arkema SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Arkema SA: Key Facts
Table 2: Arkema SA: Key Employees
Table 3: Arkema SA: Company History
Table 4: Arkema SA: Locations and Subsidiaries
Table 5: Arkema SA: Key Competitors
Table 6: Arkema SA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Arkema SA: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Arkema SA: M&A Average Deal Size - Value (US$m)
Table 9: Arkema SA: Targets and Partners
Table 10: Arkema SA: Top Deals 2016 - 2020YTD*
Table 11: Arkema SA: Legal Advisor Ranking by Value (US$m)
Table 12: Arkema SA: Financial Advisor Ranking by Value (US$m)
Table 13: Arkema SA: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Arkema SA: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: Arkema SA: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: Arkema SA: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Arkema SA: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Arkema SA: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Arkema SA: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Arkema SA: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Arkema SA: News and Events Summary
Table 22: Arkema SA: Business Expansion
Table 23: Arkema SA: Contracts
Table 24: Arkema SA: Corporate Governance
Table 25: Arkema SA: Financial Deals
Table 26: Arkema SA: Financial Performance
Table 27: Arkema SA: Market Developments
Table 28: Arkema SA: Strategy and Operations

★海外企業調査レポート[Arkema SA:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Aeroflot OAO:企業の戦略・SWOT・財務情報
    Aeroflot OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroflot OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Itochu Enex Co Ltd (8133):企業の財務・戦略的SWOT分析
    Itochu Enex Co Ltd (8133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cryostar SAS:企業の戦略的SWOT分析
    Cryostar SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • Wynn Macau Ltd:戦略・SWOT・企業財務分析
    Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report Summary Wynn Macau Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mizuho Financial Group Inc:企業のM&A・事業提携・投資動向
    Mizuho Financial Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mizuho Financial Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Marico Limited (MARICO):企業の財務・戦略的SWOT分析
    Marico Limited (MARICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Schweitzer-Mauduit International Inc (SWM):企業の財務・戦略的SWOT分析
    Schweitzer-Mauduit International Inc (SWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Saudi Arabian Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Saudi Arabian Oil Co (Saudi Aramco) is an integrated energy and chemcials company. It is a state-owned enterprise that carries out exploration, production and processing of crude oil and natural gas, refining, fractionation of natural gas, production of petrochemicals, and distribution of pe …
  • Medical Depot Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medical Depot Inc (Drive Medical) is a manufacturer and distributor of durable medical equipment. The company provides rollators, walkers, canes and crutches, commodes, bath safety, patient room , wheelchairs, power mobility, beds, pressure prevention, electrotherapy, lifestyle essentials, r …
  • BBVA Banco Frances S.A. (FRAN3):企業の財務・戦略的SWOT分析
    BBVA Banco Frances S.A. (FRAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Dynavax Technologies Corp (DVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Dynavax Technologies Corp (Dynavax), formerly Double Helix Corp, is a clinical-stage biopharmaceutical company that develops product candidates for the prevention of infectious and inflammatory disease. The company’s only marketed product Heplisav-B is an adult vaccine for hepatitis B. Its p …
  • Mitsubishi Gas Chemical Co Inc (4182):企業の財務・戦略的SWOT分析
    Mitsubishi Gas Chemical Co Inc (4182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Lloyd’s Register Group Ltd:企業の戦略的SWOT分析
    Lloyd's Register Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • DAIS Corp (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Corps (Dais) is an alternative energy company. It provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV and NanoClea …
  • Ryder System Inc (R):企業の財務・戦略的SWOT分析
    Ryder System Inc (R) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biogen Inc (BIIB):医療機器:M&Aディール及び事業提携情報
    Summary Biogen Inc (Biogen) is a global biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases worldwide. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fu …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆